774 results on '"Borrow R"'
Search Results
2. Influence of Age and Carriage Status on Salivary IgA to Neisseria meningitidis
3. Genetic Analysis of Capsular Status of Meningococcal Carrier Isolates
4. Global Meningococcal Initiative : guidelines for diagnosis and confirmation of invasive meningococcal disease
5. Improved Methods of Detection of Meningococcal DNA from Oropharyngeal Swabs from Cases and Contacts of Meningococcal Disease
6. Induction of Immunological Memory in UK Infants by a Meningococcal A/C Conjugate Vaccine
7. Salivary Antibodies Following Parenteral Immunization of Infants with a Meningococcal Serogroup A and C Conjugated Vaccine
8. Epidemiological Characterization of Methicillin-Resistant Staphylococcus aureus Isolated in the North West of England by Protein A (spa) and Coagulase (coa) Gene Polymorphisms
9. Acquisition and Carriage of Meningococci in Marine Commando Recruits
10. Following the Omicron wave, the majority of children in England have evidence of previous COVID infection
11. Non-Culture Diagnosis and Serogroup Determination of Meningococcal B and C Infection by a Sialyltransferase (SiaD) PCR ELISA
12. Variations in Neisseria meningitidis carriage by socioeconomic status : a cross-sectional study
13. The role of outer membrane proteins and lipooligosaccharide in the immunogenicity and pathogenicity of Neisseria meningitidis
14. Serum bactericidal antibody assays – The role of complement in infection and immunity
15. MBL2 deficiency is associated with higher genomic bacterial loads during meningococcemia in young children
16. Post-acute serum eosinophil and neutrophil-associated cytokine/chemokine profile can distinguish between patients with neuromyelitis optica and multiple sclerosis; and identifies potential pathophysiological mechanisms – A pilot study
17. What Would be the Best Schedule for Prevention of Meningococcal Disease in All Ages? The UK Experience
18. Immunogenicity of a single 4CMenB vaccine booster in adolescents 11 years after childhood immunisation
19. Antibody Persistence after Serogroup C Meningococcal Conjugate Immunization of United Kingdom Primary-School Children in 1999–2000 and Response to a Booster: A Phase 4 Clinical Trial
20. Seroprotection against Serogroup C Meningococcal Disease in Adolescents in the United Kingdom: Observational Study
21. SARS-CoV-2 infection, antibody positivity and seroconversion rates in staff and students following full reopening of secondary schools in England: A prospective cohort study, September-December 2020
22. Self-reported real-world safety and reactogenicity of COVID-19 vaccines: An international vaccine-recipient survey
23. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010–2017)
24. Estimated strain coverage of serogroup B meningococcal vaccines: A retrospective study for disease and carrier strains in Greece (2010–2017)
25. Invasive meningococcal disease: Timing and cause of death in England, 2008–2015
26. Inmunogenicidad e inducción de memoria inmunológica de la vacuna antineumocócica conjugada heptavalente en lactantes prematuros del Reino Unido
27. Robust SARS-CoV-2-specific T-cell immunity is maintained at 6 months following primary infection
28. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine
29. Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case–control study and a systematic review
30. A cluster of four cases of meningococcal disease in a single nuclear family
31. Chronic respiratory diseases impact pneumococcal antibody levels and response to pneumococcal vaccine.: P. 62
32. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases
33. Failure of antibody response to polysaccharide antigen in treated panhypopituitary adults
34. Mode of splenectomy and immunogenicity of meningococcal vaccination in patients with hereditary spherocytosis
35. Genomic characterization of novel Neisseria species
36. Suspected cluster of Neisseria meningitidis W invasive disease in an elderly care home: do new laboratory methods aid public health action? United Kingdom, 2015
37. Seroprotection against serogroup C meningococcal disease in adolescents in the United Kingdom: observational study
38. Development of a PCR algorithm to detect and characterize Neisseria meningitidis carriage isolates in the African meningitis belt
39. Meningococcal meningitis in two patients with primary antibody deficiency treated with replacement intravenous immunoglobulin
40. Influence of age and carriage status on salivary IgA to Neisseria meningitides
41. Role of gene polymorphisms of interleukin-10 and CD14 in meningococcal disease: P1854
42. DT5aP-Hib-IPV and MCC vaccines: preterm infants’ response to accelerated immunisation
43. Design and evaluation of a CustomSeq microarray for genotypic characterisation of Neisseria meningitides
44. Measurement and interpretation of pneumococcal IgG levels for clinical management
45. Assessing immune responses to pneumococcal vaccines
46. Impact of meningococcal C conjugate vaccine in the UK
47. Potential coverage of the 4CMenB vaccine against invasive serogroup B Neisseria meningitidis isolated from 2009 to 2013 in the Republic of Ireland
48. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study
49. Haemophilus influenzae type b (Hib) seroprevalence and current epidemiology in England and Wales
50. Lower risk of invasive meningococcal disease during pregnancy: national prospective surveillance in England, 2011–2014
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.